Clinical Trials Logo
  1. Home
  2. Pregnancy
  3. NCT00722462
  4. Details
NCT00722462 Clinical Trial

The Effect of Acupuncture on Pregnancy Rates in Women Undergoing Embryo Transfer

Pregnancy Clinical Trial

— AcuIVF  

Official title:
The Effect of Acupuncture on Pregnancy Rates in Women Undergoing Embryo Transfer After in Vitro Fertilization: A Prospective Randomized Sham-controlled Trial

Clinical Trial Details — Status: Terminated

Administrative data
NCT number NCT00722462
Other study ID # OttawaFC
Secondary ID
Status Terminated
Phase Phase 4
First received July 23, 2008
Last updated July 7, 2015
Start date August 2008
Est. completion date May 2009

Study information
Verified date July 2015
Source Ottawa Fertility Centre
Contact n/a
Is FDA regulated No
Health authority Canada: Health CanadaCanada: Canadian Institutes of Health Research
Study type Interventional

Clinical Trial Summary

The present study is designed to test the hypothesis that acupuncture, before and after embryo transfer, significantly improves pregnancy rates, compared to embryo transfer with sham acupuncture and no acupuncture at all.

Recruitment information / eligibility
Status Terminated
Enrollment 30
Est. completion date May 2009
Est. primary completion date May 2009
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- patient is undergoing embryo transfer after IVF or ICSI

- patient has given informed consent to participate

Exclusion Criteria:

- frozen embryo transfer

- previous enrollment in study

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Intervention

Procedure:
• Active acupuncture
Acupuncture 25 minutes before and after embryo transfer
• Sham acupuncture
Acupuncture at neutral points, 25 minutes before and after embryo transfer

Locations
Country Name City State
Canada Ottawa Fertility Centre Ottawa Ontario

Sponsors (1)
Lead Sponsor Collaborator
Ottawa Fertility Centre

Country where clinical trial is conducted

Canada, 

Outcome
Type Measure Description Time frame Safety issue
Primary Clinical Pregnancy 4-5 weeks after treatment No
Secondary Live birth 9 months after treatment No
Secondary Implantation rate 4-5 weeks after treatment No
Secondary Side effects with acupuncture treatment 2 weeks after treatment Yes
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Completed NCT02379728 - Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth N/A